RT @BenWestphalen: Circulating stromal cells predict inferior outcome in resectable #PancreaticCancer . Good to see a continuous expansion…
RT @BenWestphalen: Circulating stromal cells predict inferior outcome in resectable #PancreaticCancer . Good to see a continuous expansion…
RT @BenWestphalen: Circulating stromal cells predict inferior outcome in resectable #PancreaticCancer . Good to see a continuous expansion…
RT @BenWestphalen: Circulating stromal cells predict inferior outcome in resectable #PancreaticCancer . Good to see a continuous expansion…
RT @BenWestphalen: Circulating stromal cells predict inferior outcome in resectable #PancreaticCancer . Good to see a continuous expansion…
Circulating stromal cells predict inferior outcome in resectable #PancreaticCancer . Good to see a continuous expansion of blood-based analytes investigated to push the limits of #LiquidBiopsies In: @Nature_NPJ #PrecisionOncology #pancsm @OncoAlert 🚨
RT @cancerscnews: More research on circulating tumor cells! 🔬 Researchers report that CAML 🐫 assessment prior to treatment of #Pancreati…
More research on circulating tumor cells! 🔬 Researchers report that CAML 🐫 assessment prior to treatment of #PancreaticCancer predicts patients with under-staged disease and more aggressive cancer. https://t.co/Mvr5bY7cSp https://t.co/bctRmqCZMm
New article: Circulating stromal cells in resectable pancreatic cancer correlates to pathological stage and predicts for poor clinical outcomes https://t.co/k9Kd6tkDv2 #pancreaticcancer #oncology https://t.co/Iqps8FIPHC